Searched for
JB PHARMA Q3
Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- India's services exports narrow gap with goods trade as overall trade grows 5.4% in Q4FY26: NITI AayogIndia's trade saw a healthy 5.4% growth in Q4 FY26, driven by robust services exports that significantly boosted the services trade surplus...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Meesho shares rise 2% as Citi initiates coverage with Buy rating. Here's whyInternational brokerage Citi initiated coverage on Meesho with a 'Buy' rating, setting a target price of Rs 210 and anticipating a 23% upsi...
- RBI seen in no rush to press rate hike pedal, decision may get deferred to second half of FY27Economists are increasingly pushing back expectations of a Reserve Bank of India (RBI) interest rate hike, with many now seeing any tighten...
- Bharat Electronics shares in focus after defence PSU wins orders worth Rs 1,081 croreBharat Electronics shares are in focus following a significant Rs 1,081 crore order win, adding to previous gains. The defence PSU reported...
- Cochin Shipyard shares fall 3% amid buzz around OFS at 8% discountCochin Shipyard shares dipped Monday following reports of a potential government Offer for Sale (OFS) at a discount. The government, aiming...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Health insurance: Overall claims experience needs improvement in India; delays, rejections are big pain points in reimbursement, says surveyPolicybazaar's latest Health Claims Experience Index reveals that while cashless claims are preferred, the overall process needs significan...
- ICICI Prudential AMC shares fall 2% as IPO lock-in expiry frees up Rs 1.2 lakh crore stake for tradeICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...
- ITR-3 release date: Who should file this income tax return form as I-T Department enables online filing, Excel utilities for itThe Income Tax Department has launched online filing and Excel utility for Income Tax Return-3 for Assessment Year 2026-27. This form is fo...
- Quote of the day from Tay Keith: ‘I could have easily dropped out when I got the call from Drake, but I chose to focus on getting my education’. Grammy-nominated producer on choosing education over instant successGrammy-nominated producer Tay Keith prioritized completing his education at Middle Tennessee State University, becoming the first in his fa...
- Who was Tay Keith? Grammy-nominated hip-hop producer dead at 29Music producer Tay Keith has passed away at the age of 29. The Grammy-nominated artist, known for his work on hits like Travis Scott's 'Sic...
- Tay Keith cause of death: What happened to hip-hop producer? All about Brytavious Lakeith Chamber who passes away at the age of 29, watch his last live for audienceTay Keith cause of death: Tay Keith received Bachelor’s degree in Mass Communication, with a concentration in media management at Middle Te...
- Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Market Trading Guide: Allied Blenders among 2 stock recommendations for FridayDomestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
Load More
